Drug-Drug Interaction Between PK101-001 and PK101-002

NCT03553316 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

PMG Pharm Co., Ltd